Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Acceleron's ACE-083 increases muscle preclinically, enters phase I study

Oct. 14, 2015

Novel multiple ligand trap increases muscle and bone mass

Oct. 9, 2015

REV-002 reduces joint pain in phase IIa trial in acute gout arthritis

Oct. 6, 2015

Naproxcinod superior to naproxen in mouse model of DMD

Oct. 2, 2015

Heraeus Medical and OrthoCyte agree to develop stem cell based bone graft product

Oct. 2, 2015

Bone Therapeutics initiates trial of ALLOB for minimally invasive revision spinal surgery

Oct. 1, 2015

Topline results from third phase III trial of baricitinib for rheumatoid arthritis

Sep. 30, 2015

AbbVie passes on Galapagos' filgotinib, plans to advance own JAK1 inhibitor to phase III

Sep. 29, 2015

Eisai discovers inhibitor of interaction between TRAF6 and TNF superfamily receptors

Sep. 25, 2015

RuiYi initiates first human dosing of gerilimzumab

Sep. 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...